Northwestern Mutual Wealth Management CO Tg Therapeutics, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $118 Billion
- Q4 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 8,065 shares of TGTX stock, worth $321,470. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,065
Previous 20,025
59.73%
Holding current value
$321,470
Previous $468,000
48.29%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding TGTX
# of Institutions
373Shares Held
85.6MCall Options Held
3.78MPut Options Held
3M-
Vanguard Group Inc Valley Forge, PA15.6MShares$622 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$454 Million0.0% of portfolio
-
State Street Corp Boston, MA9.2MShares$367 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.19MShares$127 Million0.01% of portfolio
-
Pictet Asset Management Holding Sa Carouge, V82.79MShares$111 Million0.09% of portfolio
About TG THERAPEUTICS, INC.
- Ticker TGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 145,274,000
- Market Cap $5.79B
- Description
- TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...